Director/PDMR Shareholding
Bioventix plc announced that Chief Financial Officer Bruce Hiscock purchased 66 ordinary shares at 1,679 pence per share on April 27, 2026, through a dividend reinvestment plan. Following this transaction, Mr. Hiscock beneficially owns 1,666 ordinary shares, representing approximately 0.03 per cent. of the company's issued share capital.
Select text to share a quote on X · sign in to keep highlights & notes in your BVXP notes
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified today that on 27 April 2026 Bruce Hiscock, Chief Financial Officer of the Company, purchased a total of 66 ordinary shares of 5 pence each in the Company ("Ordinary Shares"), at a price of 1,679 pence per Ordinary Share (the "Purchase"). The Ordinary Shares were purchased under a dividend reinvestment plan ("DRIP").
Following the Purchase, Bruce Hiscock has a beneficial interest in 1,666 Ordinary Shares, representing approximately 0.03 per cent. of the issued share capital of the Company.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Bruce Hiscock |
| 2. | Reason for the Notification | |
| a) | Position/status | Chief Financial Officer |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | Bioventix Plc |
| b) | LEI | 213800225MHX7LZQY108 |
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 5 pence each |
| Identification code | GB00B4QVDF07 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 66 Ordinary Shares 1,679 pence |
| d) | Aggregated information: · Aggregated volume · Price | Purchase of 66 Ordinary Shares at 1,679 pence each |
| e) | Date of the transaction | 27 April 2026 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.